학술논문
16292 Dupilumab treatment for up to 3 years demonstrates sustained efficacy in adult patients with moderate to severe atopic dermatitis: Results from LIBERTY AD Adult OLE
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology December 2020 83(6) Supplement:AB175-AB175
Subject
Language
ISSN
0190-9622